Commentary|Articles|December 28, 2025

Interview with Sa'ed al-Olimat, PharmD: How Pharmacists are Shaping the Future of Psychedelic Therapy

Fact checked by: Laura Silvius, Managing Editor

Pharmacists must adapt to the evolving landscape of psychedelic therapies, focusing on education, patient support, and understanding regulatory challenges.

As psychedelic therapies continue to gain ground in the popular zeitgeist and edge closer to clinical use, pharmacists need to develop new competencies beyond traditional medication management. In an exclusive interview with Pharmacy Times, Sa'ed al-Olimat, PharmD, thinks the FDA's recent decision on 3,4-Methylenedioxymethamphetamine (MDMA)-assisted therapy highlights why pharmacists must be educators in this rapidly evolving therapeutic space.